iSpecimen Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
iSpecimen Inc. (ISPC) reported Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest of $2.11 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Income Statement
us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest · last filed 2023-11-02
- iSpecimen Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2023-09-30 was $2.11M, a 31.80% decline year-over-year.
- iSpecimen Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2023-06-30 was $3.50M, a 34.33% increase year-over-year.
- iSpecimen Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2023-03-31 was $2.41M, a 1.23% increase year-over-year.
- iSpecimen Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2022-09-30 was $3.10M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 9 month |
|---|---|---|---|
| 2023-09-30 | $2.11M 10-Q · filed 2023-11-02 | $5.61M derived: sum of 2 quarters · filed 2023-11-02 | $8.03M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $3.50M 10-Q · filed 2023-08-02 | $5.91M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $2.41M 10-Q · filed 2023-05-04 | ||
| 2022-09-30 | $3.10M 10-Q · filed 2023-11-02 | $5.70M derived: sum of 2 quarters · filed 2023-11-02 | $8.09M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $2.61M 10-Q · filed 2023-08-02 | $4.99M 10-Q · filed 2023-08-02 | |
| 2022-03-31 | $2.38M 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |